Results 151 to 160 of about 619,857 (348)

Trajectory‐Based Clustering to Identify Asthma Subgroups Responsive to the Selective CXCR2 Antagonist, AZD5069

open access: yes
Allergy, EarlyView.
Khezia Asamoah   +6 more
wiley   +1 more source

INVESTIGATION OF IMMUNE STATUS AND PRODUCTION CYTOKINE IN THE PATIENTS WITH ATOPIC AND MIXED-TYPE BRONCHIAL ASTHMA

open access: diamond, 2014
A. V. Zurochka   +3 more
openalex   +2 more sources

Pharmacological Considerations of Tylophora asthmatica [PDF]

open access: yes, 2003
Tylophora asthmatica has recently been included as one of the important drug from natural source for the treatment of respiratory diseases. Clinical studies have shown effectiveness of the drug in bronchial asthma and thus modern research withstands the ...
Singh, Amrit Pal
core   +1 more source

Safety and effectiveness of tirzepatide during Ramadan fasting: Real‐world evidence from patients with type 2 diabetes in Bangladesh

open access: yesDiabetes, Obesity and Metabolism, EarlyView.
Abstract Aims Ramadan fasting poses challenges for patients with type 2 diabetes mellitus (T2DM) due to increased risks of hypoglycemia and metabolic fluctuations. Tirzepatide, a dual GIP/GLP‐1 receptor agonist, has shown marked efficacy in glycemic control and weight reduction.
Muhammad Hafizur Rahman   +11 more
wiley   +1 more source

IL‐6 in the spotlight: From cardiovascular pathophysiology to therapy

open access: yesEuropean Journal of Clinical Investigation, EarlyView.
Interleukin‐6 (IL‐6) links inflammation to cardiovascular and multi‐organ dysfunction. This review integrates mechanistic, translational, and clinical evidence supporting IL‐6 as both a biomarker and therapeutic target in the continuum of cardiovascular and cardio‐renal disease.
Alberto Preda   +13 more
wiley   +1 more source

Home - About - Disclaimer - Privacy